← Eichor
Condition: Type2Diabetes Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Type2Diabetes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabet
Phase 4 · 9 location(s) · University Hospital Tuebingen · NCT06054035
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Phase 4 · 36 location(s) · Brigham and Women's Hospital · NCT05390892
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
NA · 45 location(s) · Endogenex, Inc. · NCT06267391
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Phase 2 · 1 location(s) · Adrian Vella · NCT05499702
Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial)
NA · 3 location(s) · University of Manitoba · NCT05338944
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
NA · 1 location(s) · Hospital de Clinicas de Porto Alegre · NCT06469437
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
NA · 1 location(s) · University of Michigan · NCT06337812
Depletion of Liver Fat in Type 2 Diabetes
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06211556
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
NA · 1 location(s) · Physicians Committee for Responsible Medicine · NCT05795439
Mitochondrial Substrate Utilization in the Diabetic Human Heart
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT05958706
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
NA · 1 location(s) · Ohio State University · NCT05662462
Metabolic Effects of Bariatric Arterial Embolization vs Bariatric Surgery
NA · 1 location(s) · Universidade Nova de Lisboa · NCT05859022
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes M
NA · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT07416799
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
NA · 1 location(s) · Virginia Commonwealth University · NCT07472712
Comorbidities Resolution After MGB Surgery and Change in Body Composition
Phase N/A · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06015620
Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients
Phase 2 · 1 location(s) · Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · NCT06575478
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
NA · 1 location(s) · Peking University Third Hospital · NCT05947916
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
NA · 1 location(s) · University of Michigan · NCT05603273
Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes
NA · 1 location(s) · Ian J. Neeland, MD · NCT05933174
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
NA · 1 location(s) · Ohio State University · NCT05909046
Motivational Interviewing Applied to Individuals With Diabetes
NA · 2 location(s) · Bozok University · NCT06345196
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
NA · 2 location(s) · Johns Hopkins University · NCT06364644
DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Phase 4 · 1 location(s) · Dong Wha Pharmaceutical Co. Ltd. · NCT06875193
Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"
NA · 4 location(s) · Federico II University · NCT06236932
Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
NA · 1 location(s) · Liom Health AG · NCT06272136
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
NA · 1 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT05662189
Ketones, SGLT2, HFrEF
EARLY_Phase 1 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06229678
Type 2 Diabetes and Blood Brain Barrier Improvement
EARLY_Phase 1 · 1 location(s) · University of California, Los Angeles · NCT06322212
NAD Augmentation in Diabetes Kidney Disease
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT05759468
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.